যুক্তরাজ্য - ইংরেজি - myHealthbox

octapharma limited - human coagulation factor viii, willebrand factor (vwf:rco) - powder and solvent for solution for injection - 500iu, 60iu - antihemorrhagics: blood coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)

যুক্তরাজ্য - ইংরেজি - myHealthbox

octapharma limited - human coagulation factor viii, willebrand factor (vwf:rco) - powder and solvent for solution for injection - 200iu, 120iu - antihemorrhagics: blood coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)

আর্মেনিয়া - ইংরেজি - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

csl behring gmbh - human blood coagulation factor viii, human von willebrand factor (vwf:rco) - powder and solvent for solution for injection/ infusion - 500iu+1200iu

আর্মেনিয়া - ইংরেজি - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

csl behring gmbh - human blood coagulation factor viii, human von willebrand factor (vwf:rco) - powder and solvent for solution for injection/ infusion - 1000iu+2400iu

আর্মেনিয়া - ইংরেজি - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

baxter ag - human blood coagulation factor viii/von willebrand factor(vwf:rco) - powder and solvent for solution for injection - 1000iu/750iu

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - dried factor viii fraction 250 [iu]; von willebrand's factor : ristocetin cofactor 500 [iu] - injection with diluent - 250 iu - active: dried factor viii fraction 250 [iu] von willebrand's factor : ristocetin cofactor 500 [iu] excipient: albumin calcium chloride dihydrate plasma protein sodium chloride sodium citrate dihydrate sucrose trometamol water for injection - biostate® is indicated for: · the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated

মাল্টা - ইংরেজি - Medicines Authority

octapharma (ip) limited - factor viii, human - powder and solvent for solution for injection - factor viii, human 100 iu/ml - antihemorrhagics

মাল্টা - ইংরেজি - Medicines Authority

octapharma (ip) limited - factor viii, human - powder and solvent for solution for injection - factor viii, human 200 iu/ml - antihemorrhagics

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

takeda new zealand limited - nonacog gamma 50 iu/ml equivalent to 250 iu/vial;   - powder for injection - 50 iu/ml - active: nonacog gamma 50 iu/ml equivalent to 250 iu/vial   excipient: calcium chloride dihydrate histidine mannitol polysorbate 80 sodium chloride sucrose water for injection - · routine prophylaxis of bleeding episodes in patients with haemophilia b · treatment & prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) · peri-operative management in patients with haemophilia b

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

grifols usa, llc - coagulation factor ix human (unii: 6u90y1795t) (coagulation factor ix human - unii:6u90y1795t) - coagulation factor ix human 500 [iu] in 10 ml - alphanine sd is indicated for the prevention and control of bleeding in patients with factor ix deficiency due to hemophilia b. alphanine sd contains low, non-therapeutic levels of factors ii, vii, and x, and, therefore, is not indicated for the treatment of factor ii, vii or x deficiencies. this product is also not indicated for the reversal of coumarin anticoagulant-induced hemorrhage, nor in the treatment of hemophilia a patients with inhibitors to factor viii. none known.